Most Read Articles
Jairia Dela Cruz, 23 days ago
Statins appear to have a dose-dependent association with the risk of tuberculosis (TB), with a nationwide population-based study showing that statin users have 47 percent lower incidence of TB compared with nonusers.
one month ago
At a recent lunch symposium during the 14th Annual Scientific Meeting of the Malaysian Society of Hypertension, Dr Chow Yok Wai spoke on the importance of patient adherence in the management of hypertension, highlighting the role of combination therapy in improving treatment outcomes.
Pearl Toh, 5 days ago
Individuals with high fasting plasma glucose (FPG) lost more weight than those who had low FPG in response to a high-fibre, low glycaemic load diet, suggesting that FPG could be used as a biomarker to predict dietary weight loss success and to guide selection of the most effective diet, in particular for those with prediabetes and diabetes, according to studies presented at ADA 2017.
7 days ago
Mesalazine is not superior to placebo in terms of preventing recurrence in patients with diverticulitis, according to data from two phase III trials.

Bladder training video not inferior to urotherapy for bladder/bowel dysfunction

3 months ago

The bladder training video appears to be as effective as standard urotherapy in reducing bladder/bowel symptoms in children, according to a recent study.

“The video allows families to have free access to independently review bladder training concepts as often as necessary,” researchers said.

To assess the effectiveness of an animated bladder training video, a noninferiority randomized, controlled trial was performed involving patients (aged 5 to 10 years) who scored >11 on the bladder/bowel Vancouver questionnaire. Children with vesicoureteral reflux, neuropathic bladder, learning disabilities, recent urotherapy or primary nocturnal enuresis were excluded from analysis.

Researchers randomized patients to receive either standard urotherapy or watch a bladder training video in clinic using centralized blocked randomization schemes. Then, they assessed bladder/bowel symptoms at baseline and 3-month follow-up by intent-to-treat analysis.

A sample size of 150 patients ensured a 3.5 difference in mean symptomology scores between the groups, which was accepted as the noninferiority margin.

Of the enrolled patients, a total of 143 (95 percent) completed the trial, five (4 percent) were lost to follow-up and 2 (1 percent) withdrew from the study. Baseline characteristics between the two groups were similar.

Baseline mean symptomology score was for 19.9 for the bladder training video and 19.7 for standard urotherapy. The mean symptomology scores at 3 months were reduced to 14.1 and 13.8 for the bladder training video and standard urotherapy, respectively (p=0.54). The mean difference was 0.6 (95 percent CI, ‒1.4 to ‒2.6).

“The upper 95 percent CI limit of 2.6 did not exceed the preset 3.5 noninferiority margin,” according to researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 23 days ago
Statins appear to have a dose-dependent association with the risk of tuberculosis (TB), with a nationwide population-based study showing that statin users have 47 percent lower incidence of TB compared with nonusers.
one month ago
At a recent lunch symposium during the 14th Annual Scientific Meeting of the Malaysian Society of Hypertension, Dr Chow Yok Wai spoke on the importance of patient adherence in the management of hypertension, highlighting the role of combination therapy in improving treatment outcomes.
Pearl Toh, 5 days ago
Individuals with high fasting plasma glucose (FPG) lost more weight than those who had low FPG in response to a high-fibre, low glycaemic load diet, suggesting that FPG could be used as a biomarker to predict dietary weight loss success and to guide selection of the most effective diet, in particular for those with prediabetes and diabetes, according to studies presented at ADA 2017.
7 days ago
Mesalazine is not superior to placebo in terms of preventing recurrence in patients with diverticulitis, according to data from two phase III trials.